Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Space & Defense Innovation ETF (ARKX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

ARK Space & Defense Innovation ETFTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

ARK Space & Defense Innovation ETF vs Citius Pharmaceuticals Inc — how do they compare? ARK Space & Defense Innovation ETF trades at $34.39, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: ARK Space & Defense Innovation ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

ARKXCTXR
Sector
Sector/ThematicHealth
52-Week High
$37.74$1.82
52-Week Low
$25.46$0.48
Market Cap
$20.01M
Enterprise Value
$16.23M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Space & Defense Innovation ETF

ARKX is an actively managed ETF that invests in companies leading space exploration and defense innovation. It focuses on orbital and sub-orbital aerospace, reusable rockets, and enabling technologies like AI, robotics, and satellite systems.

Read more on ARKX

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR